Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | A prognostic survival model incorporating PROs for elderly patients with multiple myeloma

In this video, Hira Mian, MD, McMaster University, Hamilton, Canada, discusses the development of a prognostic survival model incorporating patient reported outcomes (PROs) which has been designed to assist in making treatment decisions for elderly patients with multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.